A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults (clinicaltrials.gov) - Oct 10, 2026 - P1 | N=60 | Not yet recruiting | Sponsor: Adjuvia Therapeutics, Inc.
New P1 trial • Ataxia • Cardiomyopathy • CNS Disorders • Friedreich ataxia • Genetic Disorders • Metabolic Disorders • Movement Disorders
|